Vimarsana
Biggest News Aggregation in the World

Page 14 - Prospective Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prospective Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prospective Study Today - Breaking & Trending Today

Human Rights Watch's Opposition to CARE Court | Human Rights Watch - Vimarsana News

Human Rights Watch's Opposition to CARE Court | Human Rights Watch

Human Rights Watch has carefully reviewed SB 1338 and the proposed framework for the Community Assistance, Recovery and Empowerment (CARE) Court created by CalHHS. In its current form, it promotes a system of involuntary, coerced treatment, enforced by an expanded judicial infrastructure, that will, in practice, simply remove unhoused people with perceived mental health conditions from the public eye without effectively addressing those mental health conditions and without meeting the urgent need for housing. We urge you to reject the proposed framework and instead to take a more holistic, rig...

Source: hrw.org
HRW Opposition to CARE Court, California AB 2830 - Vimarsana News

HRW Opposition to CARE Court, California AB 2830

Human Rights Watch has carefully reviewed AB 2830 and the proposed framework for the Community Assistance, Recovery and Empowerment (CARE) Court created by CalHHS, and must respectfully voice our strong opposition. CARE Court promotes a system of involuntary, coerced treatment, enforced by an expanded judicial infrastructure, that will, in practice, simply remove unhoused people with perceived mental health conditions from the public eye without effectively addressing those mental health conditions and without meeting the urgent need for housing.

Source: hrw.org
Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting - Vimarsana News

Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting

Maximally sustaining IL-6 suppression in a chronic disease like NMOSD and enabling subcutaneous dosing every four weeks. Positive Phase III results for ENSPRYNG, as both monotherapy and in... | March 25, 2022

F. Hoffmann-La Roche Ltd: Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting - Vimarsana News

F. Hoffmann-La Roche Ltd: Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting

First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presentedEvrysdi data continue

Medtronic announces first patient implants of investigational implantable tibial neuromodulation therapy for bladder incontinence - Vimarsana News

Medtronic announces first patient implants of investigational implantable tibial neuromodulation therapy for bladder incontinence

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study...